China's Commerce Ministry on Thursday condemned the U.S. ban on imports from BGI Genomics (SHE:300676), Shenzhen BGI Technology, and MGI Tech (SHA:688114), calling the move "completely baseless."
Washington barred the three genomics companies over alleged forced-labor links involving Uyghurs and other ethnic minorities in Xinjiang.
The ministry said "there is no forced labor in China," and accused the U.S. of continuing to manipulate the "human rights" issue as a pretext for unilateral protectionism and bullying.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments